Grants for Schools & Universities
1,355 open opportunities. Open federal grants for colleges, universities, and other educational institutions, each with a plain-English eligibility summary, deadline, and award amount.
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers (U01 Clinical Trial Required)
Due Oct 9, 2026National Institutes of Health · Up to $1M
This NIH (NIDDK) U01 cooperative agreement funds clinical centers to join a consortium testing anti-obesity medication treatment strategies for children and adolescents with obesity. A clinical trial is required, and as a cooperative agreement NIH staff are substantially involved; applicants are typically clinical research institutions. Foreign organizations, the foreign components of U.S. organizations, and foreign components generally are not eligible or allowed. Stated funding is up to about $1,000,000; consult the NOFO for full eligibility details.
ResearchersSchools & universitiesLarge awardBroad eligibilityAlgebra and Number Theory
Due Oct 9, 2026U.S. National Science Foundation · Amount varies
This NSF Algebra and Number Theory program supports research in algebra, algebraic and arithmetic geometry, number theory, and representation theory, and also funds conferences, workshops, and summer/winter schools. Eligibility is described as unrestricted (open to any standard NSF entity type), subject to clarification in the NOFO, though proposals are typically led by universities and research organizations. Conference proposals follow specific submission windows depending on budget size. No specific award amount is stated in this record.
ResearchersSchools & universitiesBroad eligibilityOptimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center (U24 Clinical Trial Not Allowed)
Due Oct 9, 2026National Institutes of Health · Amount varies
This NIH (NIDDK) U24 cooperative agreement funds a single Research Coordinating Center to manage data, statistics, and operations for a consortium testing anti-obesity medication strategies in children and adolescents. Clinical trials are not allowed under this center role, and as a cooperative agreement NIH staff are substantially involved; this is a specialized coordinating-center award rather than a broad research grant. Foreign organizations, the foreign components of U.S. organizations, and foreign components are not eligible or allowed. No specific award amount is stated; see the NOFO for full eligibility details.
ResearchersSchools & universitiesNarrow eligibilityAddressing Methodological Challenges with Clinical Trials of Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (R01 Clinical Trial Required)
Due Oct 11, 2026National Institutes of Health · Amount varies
This NIH R01 supports research institutions and investigators studying how to design rigorous clinical trials of rapid-acting psychotropic drugs (RAPIDs) and adjunctive psychosocial interventions. A clinical trial is required, so applicants must be prepared to run one. Foreign (non-U.S.) organizations, foreign components of U.S. organizations, and foreign components generally are not eligible or allowed. The notice does not state an award ceiling; refer to the NOFO for eligibility and budget details.
ResearchersSchools & universitiesBroad eligibilityMathematical Biology
Due Oct 14, 2026U.S. National Science Foundation · Amount varies
This NSF Mathematical Biology program supports research across the mathematical sciences with relevance to biology, requiring strong integration of mathematical innovation and biological significance. Eligibility is described as unrestricted (open to any standard NSF entity type) subject to clarification in the NOFO, so a broad range of research organizations such as universities may apply; in practice proposals are typically led by institutions of higher education. The program also supports conferences and special proposal types (EAGER, RAPID, RUI). No specific award amount is stated in this record.
ResearchersSchools & universitiesBroad eligibilityNCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)
Due Oct 14, 2026National Institutes of Health · Amount varies
This NIH (NCI) K99/R00 is a career-transition award for early-stage postdoctoral cancer researchers moving toward independent faculty positions; in this version the candidate may not lead an independent clinical trial (companion NOFOs cover those who will). It is applied for through a host institution such as a university, so eligibility centers on higher-education and research institutions rather than individuals on their own. Foreign institutions and the foreign components of U.S. organizations are not eligible to apply, though some foreign components are allowed. No award ceiling is stated in this record.
ResearchersSchools & universitiesNarrow eligibilityAssay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)
Due Oct 14, 2026National Institutes of Health · Up to $250K
This NIH (NCI) UH3 award funds the clinical validation of already analytically validated molecular, cellular, or imaging biomarker assays for cancer detection, diagnosis, prognosis, monitoring, and treatment response, using specimens from clinical trials or studies. Eligible applicants include higher-education institutions, nonprofits, tribal governments, and federal agencies; clinical trials are not allowed and early-stage technology development is out of scope. Applicants must already have an analytically validated assay, which narrows who can realistically apply. Foreign organizations and foreign components of U.S. organizations are not eligible to apply; stated funding is around $250,000.
NonprofitsResearchersSchools & universitiesGovernment / tribal+1 moreDoW Melanoma Research Program Survivorship Research Award
Due Oct 14, 2026Defense Health Agency Contracting Activity - DHACA · Amount varies
This Department of War (Defense Health Agency) Melanoma Research Program Survivorship Research Award funds research aimed at improving the health and well-being of melanoma survivors, their families, and care partners, with clinical trials allowed. Eligibility is described as unrestricted (open to any standard entity type), subject to clarification in the program announcement. Note one requirement: each application must include at least one melanoma consumer collaborator (a survivor, family member, care partner, or supporting organization). Animal-model-only or survival-only studies are not responsive. No specific award amount is stated.
ResearchersSchools & universitiesBroad eligibilityDoW Melanoma Research Program Focused Program Award – Rare Melanomas
Due Oct 14, 2026Defense Health Agency Contracting Activity - DHACA · Amount varies
This Department of War (Defense Health Agency) Melanoma Research Program Focused Program Award (Rare Melanomas) funds a multidisciplinary program of two to three complementary projects addressing rare melanomas, and requires partnering Principal Investigators (an initiating PI plus one or two partnering PIs) plus at least one rare melanoma survivor or patient advocate on the team. Eligibility is described as unrestricted (open to any standard entity type), subject to clarification in the program announcement. A pre-application is required, and only invited applicants may submit a full application; clinical trials are allowed. No specific award amount is stated.
ResearchersSchools & universitiesBroad eligibilityInnovative Programs to Enhance Research Training (IPERT) (R25 Independent Clinical Trial Not Allowed)
Due Oct 14, 2026National Institutes of Health · Up to $500K
This NIH (NIGMS) R25 supports organizations developing educational and skills-training programs for the biomedical research workforce, with activities open to the broader research community and spanning career stages from undergraduates to faculty and staff scientists. Eligible applicants include higher-education institutions, nonprofits, tribal governments, faith- or community-based organizations, and federal agencies; independent clinical trials are not allowed. Foreign organizations and the foreign components of U.S. organizations are not eligible, and foreign components are not allowed. Stated funding is up to about $500,000.
NonprofitsSchools & universitiesGovernment / tribalLarge award+1 moreResearch Experiences for Teachers (RET) in Engineering and Computer Science
Due Oct 14, 2026U.S. National Science Foundation · From $600K
This NSF Research Experiences for Teachers (RET) program funds U.S. institutions of higher education to host summer research experiences for K-14 educators in engineering and computer science, fostering university-school-industry partnerships. RET Site proposals may only be submitted by accredited two- and four-year U.S. IHEs on behalf of their faculty, and the PI must be a full-time tenured or tenure-track engineering/CS faculty member; supplements are available to active ENG or CISE awardees. This is narrowly limited to higher-education institutions, not individual teachers or other organizations. Stated funding is around $600,000.
ResearchersSchools & universitiesLarge awardNarrow eligibilityAssay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
Due Oct 14, 2026National Institutes of Health · Amount varies
This NIH (NCI) UH2/UH3 award funds both analytical and clinical validation of molecular, cellular, or imaging biomarker assays for cancer detection, diagnosis, prognosis, monitoring, and treatment response. Eligible applicants include higher-education institutions, nonprofits, tribal governments, and federal agencies; clinical trials are not allowed and applicants should already have assays that work on human samples. Foreign organizations and the foreign components of U.S. organizations are not eligible to apply, though some foreign components are allowed. No specific award amount is stated in this record.
NonprofitsResearchersSchools & universitiesGovernment / tribal+1 moreRevision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)
Due Oct 14, 2026National Institutes of Health · Amount varies
This NIH (NCI) award funds revision applications to clinically validate biomarker assays that were originally developed through existing NIH-supported research grants, meaning applicants generally need an active or prior NCI-supported assay to revise. Eligible applicants include higher-education institutions, nonprofits, tribal governments, and federal agencies; clinical trials are not allowed and early-stage technology development is out of scope. Because it builds on prior NIH funding, eligibility is effectively narrow. No specific award amount is stated in this record.
NonprofitsResearchersSchools & universitiesGovernment / tribal+1 moreNCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)
Due Oct 14, 2026National Institutes of Health · Amount varies
This NIH/NCI Pathway to Independence Award (K99/R00) supports early-stage postdoctoral researchers transitioning from mentored positions to independent tenure-track faculty roles in cancer research, with an emphasis on cancer control, prevention, and data sciences. This version requires the candidate to lead an independent clinical trial; those not planning one must use the companion 'Clinical Trial Not Allowed' announcement. Applicants apply through their institutions; foreign institutions are not eligible (foreign components allowed). No specific award amount is stated.
ResearchersSchools & universitiesNarrow eligibilityDoW Melanoma Research Program Team Science Award
Due Oct 14, 2026Defense Health Agency Contracting Activity - DHACA · Amount varies
This Department of War (Defense Health Agency) Melanoma Research Program Team Science Award funds multidisciplinary melanoma research projects and requires multiple Principal Investigators (at least two and up to three) who jointly design and execute a single project, with multi-institutional partnerships encouraged. Eligibility is described as unrestricted (open to any standard entity type), subject to clarification in the program announcement. A pre-application is required, and only invited applicants may submit a full application. No specific award amount is stated in this record.
ResearchersSchools & universitiesBroad eligibilityDoW Melanoma Research Program Idea Award
Due Oct 14, 2026Defense Health Agency Contracting Activity - DHACA · Amount varies
This Department of War (Defense Health Agency) Melanoma Research Program Idea Award funds innovative, high-risk/high-reward exploratory melanoma research, with novelty emphasized and preliminary data discouraged. Eligibility is described as unrestricted (open to any standard entity type), subject to clarification in the program announcement. A pre-application is required, and investigators must be invited before submitting a full application. No specific award amount is stated in this record.
ResearchersSchools & universitiesBroad eligibilityDoW Melanoma Research Program Melanoma Academy Scholar Award
Due Oct 14, 2026Defense Health Agency Contracting Activity - DHACA · Amount varies
This Department of War (Defense Health Agency) Melanoma Research Program Melanoma Academy Scholar Award supports independent early-career investigators who are no more than seven years from their first faculty appointment, funding both their melanoma research and career development within a virtual mentoring academy; each scholar must designate an experienced Career Guide. Because it targets early-career faculty scholars, eligibility is narrow at the individual level even though the entity types are unrestricted (subject to clarification in the program announcement). Preliminary data are not required. No specific award amount is stated in this record.
ResearchersSchools & universitiesNarrow eligibilityAdvancing Research on Empirically-Supported Interventions for Older Adults Living with Serious Mental Illness (SMI) (R01 Clinical Trial Optional)
Due Oct 15, 2026National Institutes of Health · Amount varies
This NIH (NIMH) R01 funds research on delivering and improving empirically-supported mental health interventions for older adults living with serious mental illness, conducted in real-world care settings such as primary care, long-term care, and community centers; a clinical trial is optional. Unusually for this batch, foreign (non-U.S.) organizations and the foreign components of U.S. organizations are eligible to apply, and foreign components are allowed. Refer to the NOFO for full eligibility details, as the record points there rather than listing all entity types. No specific award amount is stated.
ResearchersSchools & universitiesBroad eligibilityMaximizing the Scientific Value of Data Generated by the Environmental influences on Child Health Outcomes (ECHO) Program: Dissertation Grant (R36 - Clinical Trial Not Allowed)
Due Oct 15, 2026National Institutes of Health · Amount varies
This NIH (NICHD) R36 dissertation grant supports individual doctoral candidates completing dissertation research in high-priority child health areas using data from the ECHO Cohort, a de-identified longitudinal dataset of more than 71,000 participants. Because it is a dissertation award, it is narrowly aimed at doctoral students (working through their institutions) in relevant scientific fields, not the general public or organizations broadly. Foreign organizations, the foreign components of U.S. organizations, and foreign components are not eligible or allowed. No specific award amount is stated; see the NOFO for full eligibility details.
ResearchersIndividualsSchools & universitiesNarrow eligibilityDoW Traumatic Brain Injury and Psychological Health, Translational Research Award
Due Oct 15, 2026Defense Health Agency Contracting Activity - DHACA · Amount varies
This Department of War (Defense Health Agency) Traumatic Brain Injury and Psychological Health Translational Research Award funds research that converts scientific findings into clinical applications for TBI and psychological health; basic research and clinical trials are prohibited and preliminary data are required. Eligibility is described as unrestricted (open to any standard entity type), subject to clarification in the program announcement. For prospective human-subjects research, community-based participatory research approaches are required. An early-career investigator partnering option is available. No specific award amount is stated.
ResearchersSchools & universitiesBroad eligibility